Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Pericarditis I: Introduction

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring Clinicians' Determinants of Participation in Medical Cannabis Decision Making with Older Adults Experiencing Arthritis: A Qualitative Descriptive Study.

MDM policy & practice·2026

Same author

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross-Sectional Survey Data.

Arthritis care & research·2026

Same author

Development of a Decision Aid to Support Shared Decision-Making on Cannabis Use for Arthritis: Protocol for a Multiphase Study.

JMIR research protocols·2026

Same author

Comparative performance of deep learning models and non-dermatologists in diagnosing psoriasis, dermatophytosis, and eczema.

Scientific reports·2025

Same author

The development of a cannabis risk assessment tool for patients with rheumatologic conditions: a Delphi study.

Clinical rheumatology·2025

Same author

Navigating the Roadblocks: National Patient and Provider Survey on Barriers to Healthcare and Medication Access for Patients With Vasculitis.

The Journal of rheumatology·2025

Search research articles

Related Experiment Videos

Syphilitic myositis: a case-based review.

Elaine Yacyshyn¹, Praveena Chiowchanwisawakit, Derek J Emery

¹Department of Medicine, University of Alberta, 562 Heritage Medical Research Center, University of Alberta, Edmonton, Alberta, Canada. eyacyshyn@ualberta.ca

Clinical Rheumatology

|January 7, 2011

Summary

This summary is machine-generated.

Syphilis can cause myositis, a rare muscle inflammation. This case highlights syphilis as a cause of myositis and panuveitis in an HIV/HCV co-infected patient, emphasizing diagnostic considerations.

Related Experiment Videos

Area of Science:

Infectious Diseases
Neurology
Rheumatology

Background:

Syphilis, caused by Treponema pallidum, is a complex systemic infection.
Co-infections with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) can alter disease presentation and management.
Myositis, or muscle inflammation, can have diverse etiologies, including infectious causes.

Observation:

A 49-year-old male with HIV and HCV co-infection presented with progressive muscle weakness.
Muscle biopsy revealed mild myositis, and he developed panuveitis and vertigo during prednisone therapy.
Cerebrospinal fluid (CSF) analysis confirmed syphilis (Treponema pallidum).

Findings:

The patient experienced complete clinical resolution after antibiotic treatment for syphilis.
This case illustrates myositis and panuveitis as manifestations of acute syphilis.
Syphilis is an uncommon but important cause of myositis, particularly in immunocompromised individuals.

Implications:

Syphilis should be considered in the differential diagnosis of myositis, especially in patients with HIV/HCV co-infection or those unresponsive to standard treatments.
Clinicians must consider both the underlying co-infections and potential medication side effects in patients with complex presentations.
Early diagnosis and appropriate antibiotic therapy are crucial for managing syphilitic myositis and preventing severe complications.